World Vision Salutes PAGEONE Group As Special Media Partner, Growing Its Relationship

World Vision Development Foundation, Inc. celebrated an impactful collaboration with PAGEONE Group from the pandemic up to the present, recognizing the company as its special media partner.

Filipinos Love Concerts, But Venue Infrastructure Gaps Are A Threat To The Experience

Drawing inspiration from Singapore's strategy towards concert tours that brought economic impact, the Philippines was given various considerations on how to improve a safer and fun concert experience.

Leaders Of Philippines’ Top PR Agencies To Spearhead Jury For Stevie Awards APAC 2024

The 2024 Asia-Pacific Stevie Awards has revealed exceptional Filipino PR agency leaders who will serve as the judging panel for this year's awards ceremony.

How STI College Empowers Students To Be More, In School And In Life

Unlock your full potential with STI College! Experience holistic education, innovative programs, and career guidance to become future-ready professionals.

EU Meets 70% Vaccination Target By July

0

EU Meets 70% Vaccination Target By July

0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The European Union reached its target of vaccinating 70 percent of its adult population with at least one jab by July, the bloc’s top official confirmed on Tuesday.

“The EU has kept its word and delivered,” Ursula von der Leyen, the president of the European Commission, announced in a video statement.

At least 57 percent of adults have already been fully vaccinated, she added.

Von der Leyen also warned of the dangers of the highly contagious Delta variant and urged everyone who has not been inoculated yet to get their jabs.

The European Commission set in March the objective to vaccinate 70 percent of the adult population — a minimum to reach herd immunity — by July.

The jabs were provided in the framework of bloc’s advanced purchase agreements with six vaccine producers — Pfizer/BioNTech, Moderna, AstraZeneca, CureVac, Johnson & Johnson, and Sanofi/GlaxoSmithKline — to buy about 2.6 billion vaccine doses.

In addition, the European Commission agreed with Pfizer/BioNTech to purchase another 1.8 billion doses for 2022 and 2023. (PNA)